Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
30 studies found for:    " September 19, 2007":" October 19, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" September 19, 2007":" October 19, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.
Conditions: HIV Infections;   HIV-1;   Human Immunodeficiency Virus Type 1
Interventions: Drug: TMC278;   Drug: efavirenz
2 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study
Condition: HIV Infections
Interventions: Drug: lopinavir;   Drug: atazanavir;   Drug: efavirenz;   Drug: fosamprenavir;   Drug: darunavir;   Drug: tipranavir;   Drug: ritonavir;   Drug: nevirapine;   Drug: zidovudine;   Drug: lamivudine;   Drug: tenofovir;   Drug: emtricitabine;   Drug: abacavir
3 Completed Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers
Condition: HIV Infections
Interventions: Device: TriGrid™ Delivery System;   Device: conventional intramuscular injection
4 Unknown  A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART)
Condition: HIV Infections
Intervention: Biological: EP1090
5 Completed Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence
Conditions: Opiate Dependence;   HIV Infections
Interventions: Behavioral: Enhanced Sexual Risk Management;   Behavioral: Standard Sexual Risk Management
6 Completed Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDS
Condition: HIV Infections
Intervention:
7 Completed Rapid HIV Testing Program in the Emergency Department
Condition: HIV Infections
Intervention: Other: HIV test by oral swab
8 Completed
Has Results
TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Conditions: HIV Infections;   HIV-1
Interventions: Drug: TMC278;   Drug: efavirenz
9 Unknown  Pilot Study of the Impact of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Undetectable Plasma Virus
Condition: HIV Infections
Intervention: Drug: Raltegravir (MK-0518)
10 Completed Pediatric Expanded Access Program-Oral Solution (0831-908)
Condition: HIV Infections
Intervention: Drug: MK0831
11 Unknown  The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV Patients
Conditions: HIV Infections;   Diarrhea;   Bacterial Vaginosis
Interventions: Dietary Supplement: Lactobacillus rhamnosus GR-1 + Lactobacillus reuteri RC-14;   Dietary Supplement: Placebo;   Drug: Metronidazole
12 Unknown  Diagnosis of Tuberculosis Infection in HIV Co-infected Children
Conditions: Latent Tuberculosis Infection;   Tuberculosis;   HIV Infections
Intervention:
13 Unknown  Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
14 Completed A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)
Condition: HIV Infections
Interventions: Drug: MK0639, indinavir sulfate / Duration of Treatment: 48 Weeks;   Drug: Comparator: nelfinavir mesylate / Duration of Treatment: 48 Weeks
15 Completed Bioequivalency Study of Zidovudine Under Fed Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
16 Completed Bioequivalency Study of Zidovudine Under Fasting Conditions
Condition: HIV Infections
Intervention: Drug: Zidovudine
17 Completed Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.
Conditions: Hypertriglyceridemia;   HIV Infections
Intervention: Dietary Supplement: soluble fiber® (partially hydrolyzed guar gum)
18 Completed
Has Results
Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors
Condition: HIV Infections
Interventions: Drug: Darunavir (DRV/r);   Drug: continue on current dual boosted PI
19 Completed
Has Results
Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence
Condition: HIV Infections
Interventions: Procedure: Acupuncture;   Behavioral: Relaxation Response;   Other: sham acupuncture
20 Completed The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects
Condition: HIV Infections
Interventions: Drug: nevirapine;   Drug: atazanavir/ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years